<VariationArchive VariationID="2024785" VariationName="NM_013275.6(ANKRD11):c.3603_3604del (p.Val1201_Phe1202insTer)" VariationType="Deletion" Accession="VCV002024785" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2087826" VariationID="2024785">
      <GeneList>
        <Gene Symbol="ANKRD11" FullName="ankyrin repeat domain containing 11" GeneID="29123" HGNC_ID="HGNC:21316" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89267630" stop="89490561" display_start="89267630" display_stop="89490561" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89334028" stop="89556968" display_start="89334028" display_stop="89556968" Strand="-" />
          </Location>
          <OMIM>611192</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANKRD11">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANKRD11">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_013275.6(ANKRD11):c.3603_3604del (p.Val1201_Phe1202insTer)</Name>
      <CanonicalSPDI>NC_000016.10:89282937:AGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89282938" stop="89282939" display_start="89282938" display_stop="89282939" variantLength="2" positionVCF="89282937" referenceAlleleVCF="AAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89349346" stop="89349347" display_start="89349346" display_stop="89349347" variantLength="2" positionVCF="89349345" referenceAlleleVCF="AAG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.89282939_89282940del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.89282939_89282940del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.89349347_89349348del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.89349347_89349348del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032003.2" sequenceAccession="NG_032003" sequenceVersion="2" change="g.212623_212624del">
            <Expression>NG_032003.2:g.212623_212624del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256182.2" sequenceAccession="NM_001256182" sequenceVersion="2" change="c.3603_3604del">
            <Expression>NM_001256182.2:c.3603_3604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243111.1" sequenceAccession="NP_001243111" sequenceVersion="1" change="p.Val1201_Phe1202insTer">
            <Expression>NP_001243111.1:p.Val1201_Phe1202insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256183.2" sequenceAccession="NM_001256183" sequenceVersion="2" change="c.3603_3604del">
            <Expression>NM_001256183.2:c.3603_3604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243112.1" sequenceAccession="NP_001243112" sequenceVersion="1" change="p.Val1201_Phe1202insTer">
            <Expression>NP_001243112.1:p.Val1201_Phe1202insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013275.6" sequenceAccession="NM_013275" sequenceVersion="6" change="c.3603_3604del" MANESelect="true">
            <Expression>NM_013275.6:c.3603_3604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_037407.4" sequenceAccession="NP_037407" sequenceVersion="4" change="p.Val1201_Phe1202insTer">
            <Expression>NP_037407.4:p.Val1201_Phe1202insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_013275.6(ANKRD11):c.3603_3604del (p.Val1201_Phe1202insTer) AND KBG syndrome" Accession="RCV002847953" Version="2">
        <ClassifiedConditionList TraitSetID="7213">
          <ClassifiedCondition DB="MedGen" ID="C0220687">KBG syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21782149</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25125236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25413698</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25652421</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7213" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2507" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Short stature, characteristic facies, macrodontia, mental retardation, and skeletal anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">KBG syndrome</ElementValue>
                <XRef ID="KBG+syndrome/3965" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007846" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KBGS</ElementValue>
                <XRef Type="MIM" ID="148050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="82" />
                <XRef ID="82" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">KBG syndrome is typically characterized by macrodontia (especially of the upper central incisors), characteristic facial features (triangular face, brachycephaly, synophrys, widely spaced eyes, broad or bushy eyebrows, prominent ears, prominent nasal bridge, bulbous nose, anteverted nares, long philtrum, and thin vermilion of the upper lip), short stature, developmental delay / intellectual disability, and behavioral issues. Affected individuals may have feeding difficulties (particularly in infancy), skeletal anomalies (brachydactyly, large anterior fontanelle with delayed closure, scoliosis), hearing loss (conductive, mixed, and sensorineural), seizure disorder, and brain malformations. There is significant variability in the clinical findings, even between affected members of the same family.</Attribute>
                <XRef ID="NBK487886" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29565525</ID>
                <ID Source="BookShelf">NBK487886</ID>
              </Citation>
              <XRef ID="2332" DB="Orphanet" />
              <XRef ID="C0220687" DB="MedGen" />
              <XRef ID="MONDO:0007846" DB="MONDO" />
              <XRef Type="MIM" ID="148050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5918550" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17329566|MedGen:C0220687" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003225240" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21782149</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25125236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25413698</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25652421</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ANKRD11-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe1202*) in the ANKRD11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANKRD11 are known to be pathogenic (PMID: 21782149, 25125236, 25413698, 25652421).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANKRD11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.89349346_89349347del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220687" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5918550" TraitType="Disease" MappingType="XRef" MappingValue="C0220687" MappingRef="MedGen">
        <MedGen CUI="C0220687" Name="KBG syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

